Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.77 |
| ▸ | SQLE | Q14534 | 8/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | FNTA | P49354 | 1/20 | 0.50 |
| ▸ | FNTB | P49356 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trisnorsqualene Difluoromethylidene SCHEMBL9152042 | 1.00 | KMT2A (0.77) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL9155151 | 0.93 | KMT2A (0.64) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL9155141 | 0.93 | KMT2A (0.64) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL8819997 | 0.88 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL21639794 | 0.88 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL23802597 | 0.88 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL890053 | 0.88 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| Squalene SCHEMBL21823197 | 0.88 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL8013144 | 0.88 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 | |
| SCHEMBL39067 | 0.88 | KMT2A (1.00) | KMT2ASQLEMAPTMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0448934-B1 | Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase | MERRELL DOW PHARMA (US) | 1995-02-22 | — | — | EP | claimed |
| EP-0448934-A2 | Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-10-02 | — | — | EP | claimed |
| US-5011859-A | Anticholesterol agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-04-30 | — | — | US | claimed |
| JP-4221327-A | — | — | None | — | — | JP | disclosed |
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |
| EP-0448934-B1 | Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase | MERRELL DOW PHARMA (US) | 1995-02-22 | — | — | EP | disclosed |
| US-5157166-A | Condensing difluoromethyldiphenylphosphine oxide and a polyalkylpolyunsaturated docosanal to difluoromethenylate | MERRELL DOW PHARMACEUTICALS INC. (US) | 1992-10-20 | — | — | US | disclosed |
| JP-H04221327-A | DI-OR TETRA-FLUORO ANALOG OF SQUALENE AS INHIBITOR OF SQUALENE EPOXIDASE | MERRELL DOW PHARMACEUT INC | 1992-08-11 | — | — | JP | disclosed |
| US-5064864-A | ANTICHOLESTEROL AGENTS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-11-12 | — | — | US | disclosed |
| EP-0448934-A2 | Di- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidase | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-10-02 | — | — | EP | disclosed |
| US-5011859-A | Anticholesterol agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1991-04-30 | — | — | US | disclosed |